Chest disease A proprietary sclerosing talc used to prevent recurrent malignant pleural effusions, administered by aerosol during thoracoscopy or open thoracotomy. See Sclerotherapy.
Mentioned in ?
References in periodicals archive ?
(103.) Drugs that have reached the market with no listed patents, but only regulatory exclusivity, include: Mefloquine HCl (mefloquine hydrochloride), Clozaril (clozapine), Hexalen (altretamine), Leustatin (cladribine), Trasylol (aprotinin bovine), Sclerosol (talc), and Ellence (epirubicin hydrochloride).